nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—DRD3—attention deficit hyperactivity disorder	0.496	0.591	CbGaD
Sulpiride—DRD2—attention deficit hyperactivity disorder	0.343	0.409	CbGaD
Sulpiride—CA6—saliva—attention deficit hyperactivity disorder	0.0153	0.351	CbGeAlD
Sulpiride—CA12—forebrain—attention deficit hyperactivity disorder	0.00244	0.0561	CbGeAlD
Sulpiride—Alizapride—DRD2—attention deficit hyperactivity disorder	0.00186	0.204	CrCbGaD
Sulpiride—DRD3—nervous system—attention deficit hyperactivity disorder	0.0017	0.039	CbGeAlD
Sulpiride—CA9—cerebellum—attention deficit hyperactivity disorder	0.00169	0.0387	CbGeAlD
Sulpiride—DRD3—central nervous system—attention deficit hyperactivity disorder	0.00164	0.0376	CbGeAlD
Sulpiride—Remoxipride—DRD4—attention deficit hyperactivity disorder	0.00153	0.167	CrCbGaD
Sulpiride—CA12—nervous system—attention deficit hyperactivity disorder	0.00133	0.0305	CbGeAlD
Sulpiride—DRD2—forebrain—attention deficit hyperactivity disorder	0.00133	0.0304	CbGeAlD
Sulpiride—Remoxipride—DRD3—attention deficit hyperactivity disorder	0.00132	0.144	CrCbGaD
Sulpiride—DRD3—brain—attention deficit hyperactivity disorder	0.0013	0.0298	CbGeAlD
Sulpiride—CA12—central nervous system—attention deficit hyperactivity disorder	0.00128	0.0293	CbGeAlD
Sulpiride—Amisulpride—DRD3—attention deficit hyperactivity disorder	0.00126	0.138	CrCbGaD
Sulpiride—CA2—forebrain—attention deficit hyperactivity disorder	0.00125	0.0288	CbGeAlD
Sulpiride—BCHE—forebrain—attention deficit hyperactivity disorder	0.0012	0.0276	CbGeAlD
Sulpiride—DRD2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00109	0.0101	CbGpPWpGaD
Sulpiride—DRD2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00107	0.00986	CbGpPWpGaD
Sulpiride—CA2—cardiovascular system—attention deficit hyperactivity disorder	0.00106	0.0244	CbGeAlD
Sulpiride—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.00102	0.0233	CbGeAlD
Sulpiride—CA12—brain—attention deficit hyperactivity disorder	0.00101	0.0233	CbGeAlD
Sulpiride—DRD3—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.001	0.00929	CbGpPWpGaD
Sulpiride—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—attention deficit hyperactivity disorder	0.000993	0.00918	CbGpPWpGaD
Sulpiride—DRD3—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.000965	0.00893	CbGpPWpGaD
Sulpiride—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—attention deficit hyperactivity disorder	0.000964	0.00892	CbGpPWpGaD
Sulpiride—DRD3—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.000933	0.00863	CbGpPWpGaD
Sulpiride—Remoxipride—DRD2—attention deficit hyperactivity disorder	0.00091	0.0997	CrCbGaD
Sulpiride—DRD3—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.000888	0.00822	CbGpPWpGaD
Sulpiride—DRD3—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000877	0.00812	CbGpPWpGaD
Sulpiride—DRD2—midbrain—attention deficit hyperactivity disorder	0.000875	0.0201	CbGeAlD
Sulpiride—Amisulpride—DRD2—attention deficit hyperactivity disorder	0.000873	0.0956	CrCbGaD
Sulpiride—DRD3—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.000844	0.00781	CbGpPWpGaD
Sulpiride—CA2—midbrain—attention deficit hyperactivity disorder	0.000828	0.019	CbGeAlD
Sulpiride—DRD3—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.000817	0.00756	CbGpPWpGaD
Sulpiride—BCHE—midbrain—attention deficit hyperactivity disorder	0.000794	0.0182	CbGeAlD
Sulpiride—DRD3—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.000785	0.00726	CbGpPWpGaD
Sulpiride—DRD2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.000768	0.00711	CbGpPWpGaD
Sulpiride—DRD3—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000747	0.00691	CbGpPWpGaD
Sulpiride—DRD2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.000739	0.00683	CbGpPWpGaD
Sulpiride—DRD3—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000738	0.00682	CbGpPWpGaD
Sulpiride—DRD2—Hypothetical Network for Drug Addiction—DRD1—attention deficit hyperactivity disorder	0.000732	0.00677	CbGpPWpGaD
Sulpiride—DRD2—nervous system—attention deficit hyperactivity disorder	0.000719	0.0165	CbGeAlD
Sulpiride—DRD2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.000714	0.00661	CbGpPWpGaD
Sulpiride—Remoxipride—HTR2A—attention deficit hyperactivity disorder	0.000703	0.0771	CrCbGaD
Sulpiride—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000693	0.0159	CbGeAlD
Sulpiride—DRD2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.000692	0.0064	CbGpPWpGaD
Sulpiride—DRD2—Hypothetical Network for Drug Addiction—DRD4—attention deficit hyperactivity disorder	0.000688	0.00637	CbGpPWpGaD
Sulpiride—DRD3—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000687	0.00636	CbGpPWpGaD
Sulpiride—CA2—nervous system—attention deficit hyperactivity disorder	0.000681	0.0156	CbGeAlD
Sulpiride—DRD2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00068	0.00629	CbGpPWpGaD
Sulpiride—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000677	0.0155	CbGeAlD
Sulpiride—Amisulpride—HTR2A—attention deficit hyperactivity disorder	0.000674	0.0739	CrCbGaD
Sulpiride—DRD2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000671	0.00621	CbGpPWpGaD
Sulpiride—CA9—Cellular response to hypoxia—EP300—attention deficit hyperactivity disorder	0.000657	0.00607	CbGpPWpGaD
Sulpiride—CA2—central nervous system—attention deficit hyperactivity disorder	0.000656	0.0151	CbGeAlD
Sulpiride—BCHE—nervous system—attention deficit hyperactivity disorder	0.000652	0.015	CbGeAlD
Sulpiride—DRD2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.000646	0.00597	CbGpPWpGaD
Sulpiride—CA2—cerebellum—attention deficit hyperactivity disorder	0.000641	0.0147	CbGeAlD
Sulpiride—BCHE—central nervous system—attention deficit hyperactivity disorder	0.000628	0.0144	CbGeAlD
Sulpiride—BCHE—cerebellum—attention deficit hyperactivity disorder	0.000614	0.0141	CbGeAlD
Sulpiride—DRD2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0006	0.00555	CbGpPWpGaD
Sulpiride—DRD2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.000581	0.00538	CbGpPWpGaD
Sulpiride—DRD3—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000573	0.0053	CbGpPWpGaD
Sulpiride—DRD2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000571	0.00529	CbGpPWpGaD
Sulpiride—DRD2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000564	0.00522	CbGpPWpGaD
Sulpiride—DRD2—brain—attention deficit hyperactivity disorder	0.00055	0.0126	CbGeAlD
Sulpiride—DRD3—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.000524	0.00485	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000524	0.00484	CbGpPWpGaD
Sulpiride—CA2—brain—attention deficit hyperactivity disorder	0.00052	0.012	CbGeAlD
Sulpiride—BCHE—brain—attention deficit hyperactivity disorder	0.000499	0.0115	CbGeAlD
Sulpiride—DRD3—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000481	0.00445	CbGpPWpGaD
Sulpiride—DRD2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000438	0.00405	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000401	0.00371	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.000401	0.00371	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00039	0.00361	CbGpPWpGaD
Sulpiride—DRD2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000368	0.00341	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.000352	0.00325	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000326	0.00302	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00032	0.00296	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000317	0.00294	CbGpPWpGaD
Sulpiride—CA9—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000302	0.00279	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00028	0.00259	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000275	0.00254	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000274	0.00253	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.000269	0.00249	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000268	0.00248	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000254	0.00235	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00025	0.00231	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000245	0.00226	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000243	0.00225	CbGpPWpGaD
Sulpiride—CA6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00024	0.00222	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000239	0.00221	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000231	0.00213	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000222	0.00205	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00022	0.00203	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00022	0.00203	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000214	0.00198	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000214	0.00198	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000213	0.00197	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000211	0.00195	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00021	0.00194	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000209	0.00193	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000209	0.00193	CbGpPWpGaD
Sulpiride—CA12—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000208	0.00192	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000207	0.00191	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000205	0.0019	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000194	0.00179	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000193	0.00178	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000191	0.00177	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00019	0.00176	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000185	0.00171	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000183	0.00169	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000182	0.00169	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00018	0.00167	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000179	0.00166	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000177	0.00163	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000171	0.00159	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00017	0.00157	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00017	0.00157	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000169	0.00157	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.000168	0.00156	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000168	0.00156	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000166	0.00154	CbGpPWpGaD
Sulpiride—CA6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000166	0.00153	CbGpPWpGaD
Sulpiride—CA6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000166	0.00153	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000164	0.00152	CbGpPWpGaD
Sulpiride—CA6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000163	0.00151	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000163	0.00151	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000163	0.00151	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000163	0.00151	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000162	0.0015	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000161	0.00149	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00016	0.00148	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00016	0.00148	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000159	0.00147	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000158	0.00146	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000158	0.00146	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000154	0.00143	CbGpPWpGaD
Sulpiride—CA6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000152	0.0014	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000148	0.00137	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000147	0.00136	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000146	0.00135	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000145	0.00134	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000145	0.00134	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000145	0.00134	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000144	0.00133	CbGpPWpGaD
Sulpiride—CA12—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000143	0.00133	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000143	0.00133	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000141	0.00131	CbGpPWpGaD
Sulpiride—CA12—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000141	0.0013	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00014	0.00129	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000138	0.00127	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000137	0.00127	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000135	0.00125	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000134	0.00124	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000133	0.00123	CbGpPWpGaD
Sulpiride—CA6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000133	0.00123	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000131	0.00121	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000131	0.00121	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00013	0.0012	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000127	0.00117	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000126	0.00117	CbGpPWpGaD
Sulpiride—CA6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000126	0.00117	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000125	0.00115	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000124	0.00115	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000124	0.00114	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00012	0.00111	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000118	0.00109	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000118	0.00109	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000118	0.00109	CbGpPWpGaD
Sulpiride—CA12—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000115	0.00106	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000114	0.00106	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000112	0.00104	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000112	0.00103	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000111	0.00103	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000111	0.00102	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00011	0.00102	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00011	0.00102	CbGpPWpGaD
Sulpiride—CA2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00011	0.00101	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00011	0.00101	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000109	0.00101	CbGpPWpGaD
Sulpiride—CA12—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000109	0.00101	CbGpPWpGaD
Sulpiride—CA2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000108	0.000997	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000107	0.00099	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000103	0.000952	CbGpPWpGaD
Sulpiride—CA6—Metabolism—COMT—attention deficit hyperactivity disorder	0.0001	0.000929	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.0001	0.000927	CbGpPWpGaD
Sulpiride—CA6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.97e-05	0.000922	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	9.96e-05	0.000921	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	9.67e-05	0.000895	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	9.63e-05	0.00089	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	9.47e-05	0.000876	CbGpPWpGaD
Sulpiride—CA9—Metabolism—TPH2—attention deficit hyperactivity disorder	9.24e-05	0.000854	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.24e-05	0.000854	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	9.21e-05	0.000852	CbGpPWpGaD
Sulpiride—CA9—Metabolism—DPYD—attention deficit hyperactivity disorder	9.09e-05	0.000841	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	9.02e-05	0.000834	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.99e-05	0.000832	CbGpPWpGaD
Sulpiride—CA2—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.76e-05	0.00081	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	8.71e-05	0.000805	CbGpPWpGaD
Sulpiride—CA12—Metabolism—COMT—attention deficit hyperactivity disorder	8.69e-05	0.000803	CbGpPWpGaD
Sulpiride—CA12—Metabolism—MAOA—attention deficit hyperactivity disorder	8.62e-05	0.000798	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	8.56e-05	0.000792	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	8.45e-05	0.000782	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	8.45e-05	0.000782	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.45e-05	0.000782	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	8.36e-05	0.000773	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.34e-05	0.000772	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	8.19e-05	0.000758	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	8.17e-05	0.000756	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.51e-05	0.000695	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.5e-05	0.000693	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.42e-05	0.000686	CbGpPWpGaD
Sulpiride—CA9—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.39e-05	0.000683	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.37e-05	0.000681	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.24e-05	0.00067	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	7.21e-05	0.000667	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	7.15e-05	0.000661	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.14e-05	0.000661	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.03e-05	0.00065	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.64e-05	0.000614	CbGpPWpGaD
Sulpiride—CA2—Metabolism—COMT—attention deficit hyperactivity disorder	6.64e-05	0.000614	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MAOA—attention deficit hyperactivity disorder	6.59e-05	0.00061	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.49e-05	0.0006	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.46e-05	0.000597	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.32e-05	0.000585	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.32e-05	0.000585	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.25e-05	0.000578	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.24e-05	0.000578	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.2e-05	0.000574	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.03e-05	0.000558	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.82e-05	0.000538	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.75e-05	0.000532	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.74e-05	0.000531	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.68e-05	0.000525	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.67e-05	0.000524	CbGpPWpGaD
Sulpiride—CA9—Metabolism—COMT—attention deficit hyperactivity disorder	5.6e-05	0.000518	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MAOA—attention deficit hyperactivity disorder	5.56e-05	0.000514	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.52e-05	0.00051	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.47e-05	0.000506	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.47e-05	0.000506	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.28e-05	0.000489	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	5.17e-05	0.000479	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.17e-05	0.000479	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	5.09e-05	0.000471	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.08e-05	0.00047	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.96e-05	0.000459	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.94e-05	0.000457	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.92e-05	0.000455	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.84e-05	0.000448	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.84e-05	0.000447	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.78e-05	0.000442	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.75e-05	0.000439	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.73e-05	0.000438	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.61e-05	0.000427	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.47e-05	0.000413	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.39e-05	0.000406	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.38e-05	0.000405	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.34e-05	0.000401	CbGpPWpGaD
Sulpiride—CA6—Metabolism—EP300—attention deficit hyperactivity disorder	4.31e-05	0.000398	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.14e-05	0.000383	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.07e-05	0.000377	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.94e-05	0.000364	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.83e-05	0.000354	CbGpPWpGaD
Sulpiride—CA12—Metabolism—EP300—attention deficit hyperactivity disorder	3.72e-05	0.000345	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.7e-05	0.000342	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.56e-05	0.00033	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.39e-05	0.000314	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.35e-05	0.00031	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.35e-05	0.00031	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	3.13e-05	0.00029	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.12e-05	0.000289	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.12e-05	0.000288	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	3.11e-05	0.000288	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.02e-05	0.000279	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.93e-05	0.000271	CbGpPWpGaD
Sulpiride—CA2—Metabolism—EP300—attention deficit hyperactivity disorder	2.85e-05	0.000263	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.83e-05	0.000262	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.73e-05	0.000252	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.64e-05	0.000244	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.59e-05	0.00024	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.56e-05	0.000237	CbGpPWpGaD
Sulpiride—CA9—Metabolism—EP300—attention deficit hyperactivity disorder	2.4e-05	0.000222	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.19e-05	0.000202	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.67e-05	0.000155	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	1.34e-05	0.000124	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.16e-05	0.000107	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.86e-06	8.19e-05	CbGpPWpGaD
